Artificially sweetened beverages,
does it really help with Prevention of incident type 2 diabetes?
research showsThe grade is D. One HPFS cohort analyzed 40,389 men and 2,680 diabetes cases. The top-consumption HR was 1.91 (95% CI 1.72 to 2.11) with age adjustment but 1.09 (0.98 to 1.21) after adjustment for BMI, pre-enrollment weight change, dieting, and baseline metabolic status. Most of the difference disappeared because people gaining weight or at higher diabetes risk tended to select sugar-free drinks. Two-year exclusion and lagged analyses were performed, but detailed estimates were not presented.
ads claimA current representative zero cola contains zero sugar and calories, but the cohort mixed brands, eras, and sweeteners.
Useful facts when choosing a product
- The current US Coca-Cola Zero Sugar label lists 40 mg sodium, 0 g total sugar, 0 calories, and 0 g protein per 355 mL. This is not the historical cohort-wide composition.
- Verdict 2083 is D with 30 points for aspartame and weight, while verdict 2084 is C with 50 points for sucralose and an acute glucose challenge; this verdict concerns mixed commercial beverages and long-term diabetes incidence.
What the research actually shows
de Koning followed 40,389 HPFS men for up to 20 years and documented 2,680 diabetes cases. Repeated FFQs measured diet sodas and diet drinks. The age-adjusted HR of 1.91 (1.72 to 2.11) attenuated to 1.09 (0.98 to 1.21) after adjustment including BMI, pre-enrollment weight change, dieting, and baseline metabolic status. Two-year exclusion and lagged analyses were performed, but detailed estimates were not presented. US and Canadian public or nonprofit funding was verified.
Why this is classified as D (34)
One large observational study had a null fully adjusted result, not repeated refutation, and exposure and replacement ambiguity give D with 34 points.
Counterpoint. D means the prevention claim is unsupported, not that this verdict proves the drinks cause diabetes.
Rejudgment record. Cross-check applied — Assessed change from age-adjusted to fully adjusted HRs, two-year exclusion, lagged analysis, reverse causation, and undefined replacement
| Endpoint | H | Hard endpoint - actual events such as death |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E0 | Null |
| Precision | C0 | The confidence interval leaves room for benefit |
The scoring table and the verdict agree (D).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Prevention of type 2 diabetes by artificially sweetened beverages | D | Prevention was not supported by the broadly adjusted result from one cohort. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Prospective cohort with repeated FFQs | 2,680 | NIH, Canadian Institutes of Health Research, and Canadian Diabetes Association | Incident type 2 diabetes | Age-adjusted HR 1.91 (1.72 to 2.11), fully adjusted HR 1.09 (0.98 to 1.21) | One large null prevention study demonstrating reverse confounding |
Receipt — 2 References
All 2 cited sources were verified for existence at the original page (as of 2026-08-03).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none
Cite this verdict
[Chamgap] Artificially sweetened beverages x type 2 diabetes prevention — Evidence Grade D·34. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/blood-sugar/artificially-sweetened-beverages-type-2-diabetes-prevention/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.